tiprankstipranks
Trending News
More News >
Akebia Therapeutics (AKBA)
NASDAQ:AKBA
Advertisement

Akebia Therapeutics (AKBA) Revenue

Compare
1,496 Followers

Akebia Therapeutics Revenue

Akebia Therapeutics had a revenue of 62.47M in the quarter ending Jun 30, 2025, with 8.96%. This bring the company's revenue in the last twelve months to 203.73M, Decreased 10.18%. In the fiscal year ending Dec 31, 2024, Akebia Therapeutics had annual revenue of 160.18M with -17.70% growth.
Revenue (ttm)
203.73M
Revenue Growth
16.75%
P/S Ratio
5.15
Revenue/Employee
$884,972
Employees
181
Market Cap
$824.60M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
160.18M-34.44M-17.70%
Dec 31, 2023
194.62M-97.98M-33.49%
Dec 31, 2022
292.60M79.02M+37.00%
Dec 31, 2021
213.58M-81.73M-27.68%
Dec 31, 2020
295.31M-39.69M-11.85%
Dec 31, 2019
335.00M127.26M+61.26%
Dec 31, 2018
207.74M29.76M+16.72%
Dec 31, 2017
177.98M176.45M+11,495.05%
Dec 31, 2016
1.53M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis